Improved method for the generation and selection of homogeneous lumpy skin disease virus (SA-Neethling) recombinants

Journal of Virological Methods

Volumn 146, Issue 1-2, 2007, Pages 52-60

  Wallace, David Brian ^a,b   Weyer, Jacqueline ^b   Nel, Louis Hendrik ^b   Viljoen, Gerrit Johannes ^c  

^a ONDERSTEPOORT VETERINARY INSTITUTE   (South Africa)

^b UNIVERSITY OF PRETORIA   (South Africa)

^c INTERNATIONAL ATOMIC ENERGY AGENCY   (Austria)

Author keywords

Galactosidase; Enhanced green fluorescent protein; lacZ; Lumpy skin disease virus; Recombinant capripoxvirus; Thymidine kinase

Indexed keywords

BETA GALACTOSIDASE; ENHANCED GREEN FLUORESCENT PROTEIN; VIRUS GLYCOPROTEIN;

ARTICLE; CATTLE DISEASE; ESCHERICHIA COLI; FILTRATION; GENE CONSTRUCT; GENE EXPRESSION; GENETIC MARKER; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; PROMOTER REGION; RABIES VIRUS; RIFT VALLEY FEVER BUNYAVIRUS; ULTRASOUND; VACCINIA VIRUS; VIRUS RECOMBINANT;

ANIMALS; CATTLE; CELL LINE; EPHEMERAL FEVER VIRUS, BOVINE; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; LUMPY SKIN DISEASE VIRUS; PLASMIDS; RABIES VIRUS; RECOMBINATION, GENETIC; RIFT VALLEY FEVER VIRUS; VACCINES, SYNTHETIC; VIRAL VACCINES;

BOVINE EPHEMERAL FEVER VIRUS; CAPRIPOXVIRUS; ESCHERICHIA COLI; LUMPY SKIN DISEASE VIRUS; RABIES VIRUS; RIFT VALLEY FEVER VIRUS; VACCINIA VIRUS;

EID: 35649007246     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2007.06.004     Document Type: Article

References (32)

1. Aspden K., van Dijk A., Bingham J., Cox D., Passmore J.-A., and Williamson A.-L. Immunogenicity of a recombinant lumpy skin disease virus (Neethling vaccine strain) expressing the rabies virus glycoprotein in cattle. Vaccine 20 (2002) 2693-2701
2. Aspden K., Passmore J.-A., Tiedt F., and Williamson A.-L. Evaluation of lumpy skin disease virus, a capripoxvirus, as a replication deficient vaccine vector. J. Gen. Virol. 84 (2003) 1985-1996
3. Berhe G., Minet C., Le Golf C., Barret T., Ngangnou A., Grillet C., Libeau G., Fleming M., Black D.N., and Diallo A. Development of a dual recombinant vaccine to protect small ruminants against peste-des-petits-ruminants virus and capripoxvirus infections. J. Virol. 77 (2003) 1571-1577
4. Buller R.M., Arif B.M., Black D.N., Dumbell K.R., Esposito J.J., Lefkowitz E.J., McFadden G., Moss B., Mercer A.A., Moyer R.W., Skinner M.A., and Tripathy D.N. Poxviridae. In: Fauquet C.M., Mayo M.A., Maniloff J., Desselberger U., and Ball L. (Eds). Virus Taxonomy: VIIIth report of the International Committee on Taxonomy of viruses (2006), Academic Press 117-133
5. Cheng L., Fu J., Tsukamoto A., and Hawley R.G. Use of green fluorescent protein variants to monitor gene transfer and expression in mammalian cells. Nat. Biotechnol. 14 (1996) 606-609
6. Esposito J., Condit R., and Obijeski J. The preparation of Orthopoxvirus DNA. J. Virol. Meth. 2 (1981) 175-179
7. Falkner F.G., and Moss B. Transient dominant selection of recombinant vaccinia viruses. J. Virol. 64 6 (1990) 3108-3111
8. Fick W.C., and Viljoen G.J. Identification and characterization of an early/late bi-directional promoter of the capripoxvirus, lumpy skin disease virus. Arch. Virol. 144 (1999) 1229-1239
9. Freshney R.I. Disaggregation of the tissue and primary culture. In: Liss A.R. (Ed). The Culture of Animal Cells: A Manual of Basic Technique. 3rd ed. (1994), Wiley/Liss, New York 127-147
10. Kitching R.P., Hammond J.M., and Taylor W.P. A single vaccine for the control of capripox infection in sheep and goats. Res. Vet. Sci. 42 (1987) 53-60
11. Kitching R.P., Bhat P.P., and Black D.N. The characterization of African strains of capripoxvirus. Epidemiol. Infect. 102 (1989) 335-343
12. Lennette E.H., and Schmidt N.J. Diagnostic Procedures for Viral and Rickettsial Infections. 4th ed. (1969), American Public Health Association 120
13. Mackett M., Smith G.L., and Moss B. The construction and characterization of vaccinia virus recombinants expressing foreign genes. In: Glover D.M. (Ed). DNA Cloning: A Practical Approach (1985), IRL Press, Oxford 191-221
14. Massung R.F., and Moyer R.W. The molecular biology of swinepox virus. Virology 180 (1991) 347-354
15. Merchlinsky M., and Moss B. Introduction of foreign DNA into the vaccinia virus genome by in vitro ligation: recombinant-independent selectable cloning vectors. Virology 190 (1992) 522-526
16. Nazerian K., and Dhawale S. Structural analysis of unstable intermediate and stable forms of recombinant fowlpox virus. J. Gen. Virol. 72 (1991) 2791-2795
17. Ngichabe C.K., Wamwayi H.M., Barrett T., Ndungu E.K., Black D.N., and Bostock C.J. Trial of capripoxvirus-rinderpest recombinant vaccine in African cattle. Epidemiol. Infect. 118 (1997) 63-70
18. Pfleiderer M., Falkner F.C., and Dorner E. A novel vaccinia virus expression system allowing construction of recombinants without the need for selection markers, plasmids and bacterial hosts. J. Gen. Virol. 76 (1995) 2957-2962
19. Romero C.H., Barrett T., Evans S.A., Kitching R.P., Gershon P.D., Bostock C., and Black D.N. Single capripoxvirus recombinant vaccine for the protection of cattle against rinderpest and lumpy skin disease. Vaccine 11 7 (1993) 737-742
20. Romero C.H., Barrett T., Chamberlain R., Kitching R.P., Gershon P.D., Bostock C., and Black D.N. Recombinant capripoxvirus expressing the haemagglutinin protein gene of rinderpest virus: protection of cattle against rinderpest and lumpy skin disease virus. Virology 204 (1994) 425-429
21. Romero C.H., Barrett T., Kitching R.P., Bostock C., and Black D.N. Protection of goats against peste-des-petits-ruminants with recombinant capripoxviruses expressing the fusion and haemagglutinin protein genes of rinderpest virus. Vaccine 13 1 (1994) 36-40
22. Romero C.H., Barrett T., Kitching R.P., Carn V.M., and Black D.N. Protection of cattle against rinderpest and lumpy skin disease with a recombinant capripoxvirus expressing the fusion protein gene of rinderpest virus. Vet. Rec. 43 (1994) 361
23. Sambrook J., Fritsch E.F., and Maniates T. In: Nolan C. (Ed). Molecular Cloning: A Laboratory Manual (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, USA 12-15 Appendix E
24. Timiryasova T.M., Chen B., Fodor N., and Fodor I. Construction of recombinant vaccinia viruses using PUV-inactivated virus as a helper. Biotechniques 31 (2001) 534-540
25. Wade-Evans A.M., Romero C.H., Mellor P., Takamatsu H., Anderson J., Thevasagayam J., Fleming M.J., and Mertens P.P.C. Expression of the major core structural protein (VP7) of bluetongue virus, by a recombinant capripox virus, provides partial protection of sheep against a virulent heterotypic bluetongue virus challenge. Virology 220 (1996) 227-231
26. Wallace, D.B., 1994. Characterisation of southern African strains of capripox and avipox viruses. M.Sc. Thesis. University of Cape Town, Cape Town.
27. Wallace D.B., and Viljoen G.J. Importance of thymidine kinase activity for normal growth of lumpy skin disease virus (SA-Neethling). Arch. Virol. 147 (2002) 659-663
28. Wallace D.B., and Viljoen G.J. Immune responses to recombinants of the South African vaccine strain of lumpy skin disease virus generated by using thymidine kinase gene insertion. Vaccine 23 (2005) 3061-3067
29. Wallace D.B., Ellis C.E., Espach A., Smith S.J., Greyling R.R., and Viljoen G.J. Protective immune responses induced by different recombinant vaccines to Rift Valley fever. Vaccine 26 (2006) 7181-7189
30. Wallace, D.B., 2006. An evaluation of the vaccine-vector potential of thymidine kinase-disrupted recombinants of lumpy skin disease virus (South African vaccine). Ph.D. Thesis. University of Pretoria.
31. Weiss K.E. Lumpy skin disease. Virol. Monogr. 3 (1968) 111-131
32. Weyer, J., 2006. Immune responses against recombinant poxvirus vaccines that express full-length lyssavirus glycoprotein genes. Ph.D. Thesis. University of Pretoria.